Stay updated on REOLYSIN in KRAS Mutant CRC Clinical Trial
Sign up to get notified when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.

Latest updates to the REOLYSIN in KRAS Mutant CRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check41 days agoChange DetectedNo additions or deletions were observed. The page content appears unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.4.2 added; the funding-lapse notice and Revision: v3.4.1 were removed; these are site-wide updates and do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedA site-wide notice about a lapse in government funding and the page revision updated to v3.4.1 were added, replacing the previous revision v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check69 days agoChange DetectedAdded a glossary toggle and updated QC-related wording (Last Update Submitted that Met QC Criteria) and the revision label (Revision: v3.4.0); No FEAR Act data wording was adjusted. These are metadata/UX changes and do not modify core study content, eligibility criteria, or results.SummaryDifference0.2%

Stay in the know with updates to REOLYSIN in KRAS Mutant CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.